Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0523 Transporter Info | ||||
Gene Name | CACNG2 | ||||
Protein Name | Voltage-dependent calcium channel gamma-2 | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs2284018 | ||||
Site of GPD | chr22:36701519 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>G / C>T | ||||
Minor Allele Frequency | T=0.2338/901 (Global) | ||||
Genotype TT | Click to Show/Hide the Full List of Affected Drugs: 3 Drugs in Total | ||||
Lithium | N.A. | Pain, Postoperative | Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotypes CC + CT. | [ 1] | |
Lithium | N.A. | Bipolar Disorder | Genotype TT is associated with decreased response to lithium in people with Bipolar Disorder as compared to genotypes CC + CT. | [ 1] | |
Lithium | N.A. | Bipolar Disorder | Correlated with the decreased drug response in patients (compare with genotypes CC + CT) | [ 1] | |
Genotype CC | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Lithium | N.A. | Bipolar Disorder | Patients with the CC genotype and Bipolar Disorder may be more likely to respond to lithium as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's response to lithium. | [ 1] | |
Genotype CT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Lithium | N.A. | Bipolar Disorder | Patients with the CT genotype and Bipolar Disorder may be more likely to respond to lithium as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's response to lithium. | [ 1] | |
Genetic Polymorphism | rs2284017 | ||||
Site of GPD | chr22:36700882 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | T>C / T>G | ||||
Minor Allele Frequency | T=0.5790/1145 (Global) | ||||
Allele C | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
Lithium | N.A. | Pain, Postoperative | Allele C is associated with increased response to lithium in people with Bipolar Disorder as compared to allele T. | [ 1] | |
Lithium | N.A. | Bipolar Disorder | Allele C is associated with increased response to lithium in people with Bipolar Disorder as compared to allele T. | [ 1] | |
Genotype CC | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
Lithium | N.A. | Pain, Postoperative | Genotype CC is associated with increased response to lithium in people with Bipolar Disorder. | [ 2] | |
Lithium | N.A. | Bipolar Disorder | Genotype CC is associated with increased response to lithium in people with Bipolar Disorder. | [ 2] | |
Genotype CT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Lithium | N.A. | Bipolar Disorder | Patients with the CT genotype may have increased response to lithium as compared to patients with the TT genotype. Other genetic and clinical factors may also influence a patient's response to treatment. | [ 2] | |
Genotype TT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Lithium | N.A. | Bipolar Disorder | Patients with the TT genotype may have decreased response to lithium as compared to patients with the CC genotype. Other genetic and clinical factors may also influence a patient's response to treatment. | [ 2] | |
References | |||||
1 | Stargazin involvement with bipolar disorder and response to lithium treatment. Pharmacogenet Genomics. 2008 May;18(5):403-12. | ||||
2 | Pharmacogenetics of lithium response in bipolar disorder. Pharmacogenomics. 2010 Oct;11(10):1439-65. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.